Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Novocure Ltd Ord Sh
(NQ:
NVCR
)
15.63
+0.02 (+0.13%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Novocure Ltd Ord Sh
< Previous
1
2
...
10
11
12
13
14
15
16
17
Next >
Calm Markets Day
May 07, 2021
Despite seriously disappointing April jobless numbers, markets are gaining all the same.
Via
Talk Markets
Finns and Danes
May 05, 2021
Stock markets are still uncertain whether to rise or fall after the Tuesday debacle.
Via
Talk Markets
Cramer Weighs In On Penn National Gaming, Palantir And More
May 04, 2021
On CNBC's "Mad Money Lightning Round," Jim Cramer said he happens to like Penn National Gaming, Inc (NASDAQ: PENN) very much and it deserves to trade higher. Alcoa (...
Via
Benzinga
Unusually Heavy Friday
April 30, 2021
Today is a heavy news day, which is unusual for a Friday. We start with the largest company's lamentable report, follow with another confusing result, then a hopeful drug company report, and finish...
Via
Talk Markets
Recap: NovoCure Q1 Earnings
April 29, 2021
Shares of NovoCure (NASDAQ:NVCR) fell 2.7% in pre-market trading after the company reported Q1 results. Quarterly Results Earnings per share were down 200.00% year over...
Via
Benzinga
Earnings Scheduled For April 29, 2021
April 29, 2021
Companies Reporting Before The Bell • OSI Systems (NASDAQ:OSIS) is estimated to report quarterly earnings at $1.33 per share on revenue of $290.51 million. •...
Via
Benzinga
Stock Market Rally Navigates Earnings From Apple, Tesla, Google, Facebook, Microsoft, Amazon
April 30, 2021
The stock market rally navigated earnings from Apple, Tesla and the other "big six" market cap companies. Many breakouts, but not all succeeded.
Via
Investor's Business Daily
Is Novocure Stock Overvalued?
April 30, 2021
Did the market overreact to the company's good news?
Via
The Motley Fool
Another Heavy News Day
April 29, 2021
For whatever it is worth, markets seem keen on the proposed measures, boosted by a nicely lower level of new unemployment insurance claims last week.
Via
Talk Markets
NovoCure (NVCR) Q1 2021 Earnings Call Transcript
April 29, 2021
NVCR earnings call for the period ending March 31, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
The Daily Biotech Pulse: Clinical Setback For Adverum, Galera Posts Data Readout, Moderna To Invest In Vaccine Manufacturing, Decision Day For Ardelyx
April 29, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 28) Axonics, Inc. (NASDAQ:...
Via
Benzinga
Novocure Reports Surprise Loss As Revenue Falls Short
April 29, 2021
Novocure reported a surprise loss as the cancer-fighting medtech missed on revenue. NVCR stock fell.
Via
Investor's Business Daily
Novocure Reports First Quarter 2021 Financial Results and Provides Company Update
April 29, 2021
From
Novocure
Via
Business Wire
London Cancel
April 26, 2021
Brazilian Cosan is up 0.43% despite desperate Covid-19 outbreaks along the Amazon.
Via
Talk Markets
Exposures
COVID-19
Earth Day
April 22, 2021
Once again the exchanges are unsure if they want to go up or down.
Via
Talk Markets
The Daily Biotech Pulse: FDA Rejection For Protalix, Amgen Q1 Trail Estimates, Pfizer Goes Shopping
April 28, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 27) Aldeyra Therapeutics, Inc...
Via
Benzinga
Exposures
Product Safety
Novocure Announces FDA IDE Approval and Steering Committee for KEYNOTE-B36 Trial Evaluating Tumor Treating Fields Together with Pembrolizumab in Non-Small Cell Lung Cancer
April 22, 2021
From
Novocure
Via
Business Wire
The Daily Biotech Pulse: Lilly, Novartis Trail Q1 Estimates, Exec Departure At Applied Genetics, Patent Award For Scholar Rock, Aldeyra Data Readout
April 27, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 26) 10x Genomics, Inc. (NASDAQ...
Via
Benzinga
Topics
Intellectual Property
Exposures
Intellectual Property
Cancer Therapy Novocure Stock Still On A High As It Clears Technical Benchmark
April 21, 2021
Cancer therapy Novocure stock had its Relative Strength (RS) Rating upgraded from 90 to 93 Wednesday. It's also an IBD 50 member.
Via
Investor's Business Daily
Is Novocure a Buy?
April 20, 2021
Once a stock goes up 50% in a single day, it can be hard to keep the momentum going.
Via
The Motley Fool
The Week Ahead In Biotech (April 25-May 1): FDA Decisions For Sol-Gel, Protalix Bio, Ardelyx
April 24, 2021
Biopharma stocks came back from the weakness seen in the first two sessions to close the week ended April 23 higher. Johnson & Johnson (NYSE: JNJ) and Roche Holding AG (OTC:...
Via
Benzinga
Exposures
Product Safety
Why Investors Are So Excited About Novocure
April 20, 2021
The company's Tumor Treating Fields therapy looks very promising in treating lung cancer.
Via
The Motley Fool
Currency Manipulation
April 16, 2021
London's FTSE 100 index today rose over 7000 for the first time in 14 months. It hit 7019.53.
Via
Talk Markets
Stock Market Rally Keeps Rising As Treasury Yields Fall Despite Strong Earnings, Economic Data; Goldman, Nvidia, Coinbase In Focus
April 16, 2021
Tumbling yields and strong economic data fueled stocks. Goldman earnings, Nvidia news and the Coinbase IPO were in focus.
Via
Investor's Business Daily
Topics
Initial Public Offering
Stocks
Exposures
Securities Market
US Equities
This Stock Just Popped 40%. Here's Why It Can Continue to Crush the Market
April 16, 2021
Novocure has provided stellar returns over the last five years, now up 17 times. Recent positive news may keep its stock going up.
Via
The Motley Fool
Happy News Day
April 15, 2021
The stock markets are in clover because March retail sales hit 9.8% according to the Department of Commerce.
Via
Talk Markets
Stunning Market Debut
April 14, 2021
Wednesday brought a zip into the accounts of many financial stocks thanks to a boom result from Goldman Sachs GS, which boosted its competitors' prices.
Via
Talk Markets
Cancer Therapy Novocure Stock Flashes Renewed Technical Strength
April 14, 2021
Novocure stock saw a welcome improvement to its Relative Strength (RS) Rating on Wednesday, with an increase from 67 to 92.
Via
Investor's Business Daily
Benzinga's Top Ratings Upgrades, Downgrades For April 14, 2021
April 14, 2021
Upgrades For Cardlytics Inc (NASDAQ:CDLX), Craig-Hallum upgraded the previous rating of Hold to Buy. For the fourth quarter, Cardlytics had an EPS of $0.05, compared to...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
April 14, 2021
Gainers Akumin (NASDAQ:AKU) shares increased by 13.54% to $3.52 during Wednesday's pre-market session. The market value of their outstanding shares is at $247.0...
Via
Benzinga
< Previous
1
2
...
10
11
12
13
14
15
16
17
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.